To Evaluate the Effect of Immune Checkpoint Inhibitors on Bladder Cancer: Efficacy, Safety and Prognostic of Geriatrics

被引：0
|
作者：
Zhang, Chuan [1 ]
Wang, Hao [1 ]
Li, Yue [2 ]
Zhang, Li [1 ]
Wang, Kai [1 ]
Liu, Hao [1 ]
Hu, Fugui [1 ]
机构：
[1] Chengdu Univ Chinese Tradit Med, Dept Urol, Chengdu Peoples Hosp 5, Chengdu, Peoples R China
[2] Chengdu Univ Chinese Tradit Med, Dept Qual Control, Chengdu Peoples Hosp 5, Chengdu, Peoples R China
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2021年 / 128卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
0208
引用
收藏
页码：9 / 10
页数：2
相关论文
共 50 条
  • [1] Effect of KDR mutations on efficacy of immune checkpoint inhibitors in patients with bladder cancer.
    Dai, Honghai
    Zhang, Qin
    Tan, Yuan
    Duan, Qianqian
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [2] Immune Checkpoint Inhibitors for Cancer Therapy: Clinical Efficacy and Safety
    Azoury, Said C.
    Straughan, David M.
    Shukla, Vivek
    CURRENT CANCER DRUG TARGETS, 2015, 15 (06) : 452 - 462
  • [3] Effect of NCOR1 Mutations on Immune Microenvironment and Efficacy of Immune Checkpoint Inhibitors in Patient with Bladder Cancer
    Lin, Anqi
    Qiu, Zhengang
    Zhang, Jian
    Luo, Peng
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [4] Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy
    Le, Jiayuan
    Sun, Yuming
    Deng, Guangtong
    Dian, Yating
    Xie, Yanli
    Zeng, Furong
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2025, 21 (01)
  • [5] Immune checkpoint inhibitors for metastatic bladder cancer
    Massari, Francesco
    Di Nunno, Vincenzo
    Cubelli, Marta
    Santoni, Matteo
    Fiorentino, Michelangelo
    Montironi, Rodolfo
    Cheng, Liang
    Lopez-Beltran, Anto
    Battelli, Nicola
    Ardizzoni, Andrea
    CANCER TREATMENT REVIEWS, 2018, 64 : 11 - 20
  • [6] Immune checkpoint inhibitors for metastatic bladder cancer
    Cubelli, Marta
    Di Nunno, Vincenzo
    Rihawi, Karim
    Massari, Francesco
    TRANSLATIONAL CANCER RESEARCH, 2017, 6 : S720 - S732
  • [7] Immune Checkpoint Inhibitors for the Treatment of Bladder Cancer
    Lopez-Beltran, Antonio
    Cimadamore, Alessia
    Blanca, Ana
    Massari, Francesco
    Vau, Nuno
    Scarpelli, Marina
    Cheng, Liang
    Montironi, Rodolfo
    CANCERS, 2021, 13 (01) : 1 - 16
  • [8] Efficacy of immune checkpoint inhibitors (ICIs) in rare histological variants of bladder cancer
    Philip, Errol James
    Wright, Francis
    Kim, Daniel Myung
    Kwon, Daniel
    Ho, Hansen
    Ho, Son
    Cheung, Edna
    Chan, Emily
    Porten, Sima P.
    Wong, Anthony C.
    Borno, Hala
    Desai, Arpita
    Chou, Jonathan
    Oh, David Yoonsuk
    Aggarwal, Rahul Raj
    Fong, Lawrence
    Small, Eric Jay
    Friedlander, Terence W.
    Koshkin, Vadim S.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [9] Safety, efficacy and prognostic impact of immune checkpoint inhibitors in older patients with genitourinary cancers
    Schulz, Gerald Bastian
    Rodler, Severin
    Szabados, Bernadett
    Graser, Annabel
    Buchner, Alexander
    Stief, Christian
    Casuscelli, Jozefina
    JOURNAL OF GERIATRIC ONCOLOGY, 2020, 11 (07) : 1061 - 1066
  • [10] Safety and Efficacy of Personalized Cancer Vaccines in Combination With Immune Checkpoint Inhibitors in Cancer Treatment
    Liao, Juan-Yan
    Zhang, Shuang
    FRONTIERS IN ONCOLOGY, 2021, 11
12345